Drug
Gadobutrol
Gadobutrol: highest development phase Phase 3, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Gadobutrol (Gadovist, BAY86-4875) NCT01050829 | Phase 3 | Magnetic Resonance Imaging |
Latest
No recent events.
Follow Gadobutrol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.